Humana Inc. (NYSE:HUM) Shares Bought by Resona Asset Management Co. Ltd.

Key Points

• Resona Asset Management Co. Ltd. increased its stake in Humana Inc. by 7.4%, acquiring an additional 2,958 shares and bringing its total holdings to 42,795 shares valued at approximately $11.32 million.
• Institutional investors collectively own 92.38% of Humana's stock, with significant increases in holdings from other firms like Vanguard Group and Pzena Investment Management in the first quarter.
• Humana's stock has recently fluctuated, with a 52-week low of $206.87 and a high of $382.72, and reports show the company missed earnings estimates, recording $6.27 EPS against expectations of $6.32.

Resona Asset Management Co. Ltd. grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 7.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 42,795 shares of the insurance provider's stock after buying an additional 2,958 shares during the period. Resona Asset Management Co. Ltd.'s holdings in Humana were worth $11,323,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Humana by 8.9% during the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after buying an additional 1,143,662 shares in the last quarter. Pzena Investment Management LLC boosted its holdings in shares of Humana by 6.1% during the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock worth $1,013,133,000 after purchasing an additional 219,541 shares during the last quarter. Davis Selected Advisers boosted its holdings in shares of Humana by 3.3% during the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock worth $616,873,000 after purchasing an additional 74,434 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Humana by 11.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider's stock worth $407,401,000 after purchasing an additional 160,952 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Humana by 14.5% during the fourth quarter. Northern Trust Corp now owns 1,216,195 shares of the insurance provider's stock worth $308,561,000 after purchasing an additional 153,739 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Up 1.9%

Shares of NYSE:HUM traded up $5.39 during trading on Friday, hitting $286.73. The company's stock had a trading volume of 1,738,591 shares, compared to its average volume of 2,075,797. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72. The stock's 50-day moving average price is $242.70 and its two-hundred day moving average price is $253.82. The company has a market capitalization of $34.49 billion, a PE ratio of 22.01, a PEG ratio of 1.65 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.96 earnings per share. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Truist Financial decreased their price objective on Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a report on Wednesday, July 16th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 target price on shares of Humana in a report on Thursday, May 1st. Morgan Stanley reduced their target price on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Barclays set a $275.00 target price on Humana and gave the company an "equal weight" rating in a report on Thursday, July 31st. Finally, Wells Fargo & Company reduced their target price on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a report on Thursday. Eighteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Humana presently has an average rating of "Hold" and an average price target of $281.45.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.